QualityStocksNewsBreaks Archives - Page 26 of 1576

FridayMay 15, 2026 10:30 am

QualityStocksNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in NetworkNewsAudio Editorial on Next-Generation GLP-1 Therapies

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) was featured in a NetworkNewsAudio audio press release examining the evolution of the GLP-1 treatment market, highlighting the company’s development of GEP-44, a patented next-generation metabolic therapy designed to improve on first-generation GLP-1 drugs. The editorial noted GEP-44’s triple agonist mechanism targeting GLP-1 and peptide YY receptors, with preclinical data indicating potential benefits in appetite suppression, weight reduction and glycemic control with improved tolerability. To view the full press release, visit https://ibn.fm/wsiDy About SureNano Science Ltd. SureNano Science Ltd. (CSE:…

FridayMay 15, 2026 9:50 am

QualityStocksNewsBreaks – SOLOWIN HOLDINGS (NASDAQ: AXG) Subsidiary AX Coin Partners With INFINIOS on Stablecoin Payment Infrastructure

SOLOWIN HOLDINGS (NASDAQ: AXG) announced that its AX Coin stablecoin subsidiary has signed a non-binding memorandum of understanding with INFINIOS to develop regulated wallet infrastructure and digital payment solutions aimed at accelerating stablecoin adoption across the Gulf region. The collaboration is expected to integrate AX Coin into INFINIOS’ payments infrastructure, enabling compliant custodial and non-custodial wallet solutions, multi-currency virtual accounts, fiat on/off ramps, and real-time cross-border settlement capabilities for institutional clients. To view the full press release, visit https://ibn.fm/Hpyle About SOLOWIN HOLDINGS SOLOWIN HOLDINGS (Nasdaq: AXG) is a leading global regulated fintech company. Established in 2016, AXG combines blockchain and…

FridayMay 15, 2026 9:45 am

GPS Jamming: The Growing Threat of a Cheap and Effective Weapon of War

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. GPS jamming is quickly turning into a common weapon in war, as it disrupts and interrupts many of the crucial aspects of modern wars, such as communication, navigation, and precision targeting. However, GPS jamming isn’t only felt in war, as the effects can expand beyond the battlefield and impact civilians in frustrating and potentially dangerous ways. Companies like SPARC AI Inc. are developing GPS-free navigation and target acquisition software that continue to operate even in GPS-denied areas. Navigation interference has emerged as one of…

FridayMay 15, 2026 9:30 am

QualityStocksNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Reports Fiscal Second Quarter Results, Advances Solana Treasury Strategy

Forward Industries (NASDAQ: FWDI) reported fiscal second-quarter 2026 results, highlighting strategic actions to strengthen its balance sheet and expand its Solana-focused treasury strategy, including a $40 million institutional debt facility with Galaxy Digital, a $27.4 million share repurchase that reduced basic shares outstanding by 7.4%, and implementation of a cost reduction plan expected to lower quarterly SG&A expenses. The company also announced a strategic investment in OnRe and plans to deploy up to $25 million into its yield-bearing token, expanding exposure to tokenized real-world assets while diversifying revenue streams beyond its core SOL-focused strategy. To view the full press release,…

FridayMay 15, 2026 9:10 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Reports First Quarter Revenue Growth, Improved Loss Metrics

Beeline Holdings (NASDAQ: BLNE) reported first-quarter 2026 net revenue of $2.7 million, more than doubling from the prior-year period, driven by loan originations of $85.6 million across 288 loans compared with $39.8 million across 128 loans a year earlier. The company reported a net loss of $5.3 million, improved from $6.9 million in the prior-year quarter, while adjusted EBITDA loss narrowed to $3.0 million from $3.8 million, as Beeline continued expanding its capital-light BeelineEquity platform and reiterated its goal of reaching a $100 million revenue run rate by the end of 2027. To view the full press release, visit https://ibn.fm/Kxh6r…

FridayMay 15, 2026 9:00 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) CEO Highlights AI Voice Detection Platform and Workplace Rollout Plans During TechMediaWire Podcast

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. During a recent TechMediaWire Podcast appearance, Justin Hanka outlined MindBio Therapeutics’ progress in developing advanced AI-driven voice analysis technology for drug and alcohol intoxication detection. MindBio Therapeutics Corp. says its prediction models are trained using more than 50 million data points collected through years of clinical and behavioral research. The company’s initial commercial strategy focuses on workplace safety sectors including mining, aviation, and construction, where impairment-related incidents carry significant operational and regulatory risks. Hanka said during the interview that the company’s voice-analysis platform can…

ThursdayMay 14, 2026 11:58 am

QualityStocksNewsBreaks – BluSky AI Inc. (OTCID: BSAI) Launches Regulation A+ Offering to Support AI Infrastructure Expansion

BluSky AI (OTCID: BSAI) announced the launch of a Regulation A+ offering aimed at enabling individual and accredited investors to participate in the company’s planned expansion of its distributed AI infrastructure network, with a minimum investment of $1,000. Proceeds are intended to support development of BluSky AI’s modular AI Factory footprint across the United States, including expansion of its Neocloud compute capacity designed to serve growing demand for large-scale AI training and inference workloads. To view the full press release, visit https://ibn.fm/Vm1i5 About BluSky AI Inc. Headquartered in Salt Lake City, Utah, BluSky AI Inc. (the “Company” or “BlueSky AI”) is a Neocloud purpose-built for artificial intelligence through rapidly…

ThursdayMay 14, 2026 11:44 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Highlights Strategic Washington Engagements, Provides Corporate Update

American Fusion (OTC: AMFN) provided an update on recent strategic engagements in Washington, D.C., where the company discussed potential applications for its Texatron(TM) Fusion Engine(TM) platform across defense, infrastructure and national energy resilience initiatives. The company also outlined corporate progress, including anticipated Form 10 effectiveness, advancement of its Rule 15c2-11 quotation application, pursuit of OTCQB qualification and continued development of its 5MW Texatron pre-production unit as it advances commercialization and capital markets objectives. To view the full press release, visit https://ibn.fm/hevBS About American Fusion Inc. American Fusion Inc. (OTC: AMFN) is an advanced energy platform company focused on the development and commercialization of next-generation fusion energy technologies. The Company is advancing…

ThursdayMay 14, 2026 11:35 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on CNS Drug Delivery Innovation

Oncotelic Therapeutics (OTCQB: OTLC) announced its featured placement in a BioMedWire editorial focused on emerging CNS drug delivery technologies addressing challenges in Alzheimer’s disease and biodefense research. The editorial highlights the company’s proprietary intranasal nose-to-brain delivery platform, designed to bypass the blood-brain barrier and enable direct therapeutic delivery to the central nervous system, reflecting growing interest in advanced drug delivery approaches for neurological treatment. To view the full press release, visit https://ibn.fm/wgFw3 About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The Company’s mission is to address high-unmet-need cancers and rare pediatric indications with innovative, late-stage…

ThursdayMay 14, 2026 11:27 am

QualityStocksNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Emerging GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its featured placement in a BioMedWire editorial examining next-generation innovation in the rapidly expanding GLP-1 therapeutic market. The editorial highlights the company’s subsidiary GlucaPharm Inc. and its development of GEP-44, a novel triple agonist peptide designed to enhance efficacy, tolerability and delivery flexibility in the treatment of obesity, type 2 diabetes and related metabolic conditions. To view the full press release, visit https://ibn.fm/X8Dwj About SureNano Science Ltd. SureNano Science Ltd. (CSE: SURE) is a Canadian life sciences company focused on acquiring, developing, and advancing innovative pharmaceutical and biotechnology assets with the potential to address large and growing…

Site Search

Company Search

Category: QualityStocksNewsBreaks